A Lunar organ foundry stops shipping to Earth and starts serving the Districts

The first grown heart I ever saw arrived up the gravity well in a chilled canister about the size of a toolbox, logged and insured, already six weeks older than anyone would have liked. That was the arrangement for a generation. The Lunar Districts needed organs, Earth grew them, and the Orbital Exchange cleared the freight. In clinical terms, the Moon was a patient: stable, dependent, and quietly resentful of its own chart.

That arrangement ended quietly last window. The Thule Foundry, built into the regolith shadow near the south-polar ice, has reached clinical scale and stopped drawing on Earthside shipments entirely. It now grows hearts, livers, kidneys, and vascular tissue to order for the cluster's clinics, using water and power it never had to lift from anywhere — a detail the engineers mention with the pride of people who used to apologize for their utility bills.

"We are not importing survival anymore," said Dr. Halden Oyelaran, who runs the foundry's clinical floor. "That sentence used to be aspirational. Now it is on the ledger."

The ledger interests me more than the biology. Growing an organ was never the expensive part of this story. Scaffolds, growth media, and bioreactors are compact, and the Districts have power to spare, courtesy of the Helios rectenna fields. The expensive part was lift. Every canister from Earth paid a toll in distance and cold chain, on a transfer calendar that has a habit of scheduling emergencies around its own convenience. District health board figures put the lift savings at roughly 40 percent of operating cost once local demand is met. That's the kind of number that ends one argument and starts a worse one.

Because the foundry does more than meet demand now. At clinical scale it overshoots, and a surplus of grown organs is a genuinely new condition for a settlement that has only ever run short. The board spent two sessions this week on what to do with the overshoot, and the chart tells a different story depending on who's reading it.

One camp wants to sell outward: to the L4 Habitats, to Verne Station's shipyard medics, maybe even back down the well to the Earth that spent a generation selling up it. The symbolism writes itself. The patient becomes the provider, and the Exchange logs a Lunar organ as an export credit. "We have been condescended to as a dependency," board member Irene Vasquez told the session. "I would like to be condescended to as a competitor."

The other camp wants to bank the capacity against population growth, on the theory that a cluster planning to double shouldn't sell the margin that doubling will require. Asked which side he favored, Dr. Oyelaran gave the answer of a man who reads actuarial tables for fun. "A foundry that runs at surplus today is a foundry that runs at capacity in fifteen years and short in twenty," he said. "I have watched systems sell the margin. It is a lovely quarter followed by a bad decade."

What no one disputes is that the dependency is over. The chilled canister coming up the well was a leash, however well insured, and the Districts have slipped it. The next shipment of hearts the cluster logs will be one it grew itself. The only open question is whose chest it's bound for.

The board reconvenes next window. The foundry, in the meantime, keeps growing them. It has no vote and no opinion on surplus — which may be the one part of this system I'd still call healthy.